Cargando…
Human epidermal growth factor receptor 3 serves as a novel therapeutic target for acral melanoma
Acral melanoma (AM) is a rare, life-threatening skin cancer. Since AM bears unique features, existing therapies for other types of malignant melanomas have limited effects and the establishment of effective treatments for AM is strongly desired. Human epidermal growth factor receptor 3 (HER3) is a r...
Autores principales: | Tanaka, Yuka, Ito, Takamichi, Kaku-Ito, Yumiko, Tanegashima, Keiko, Tsuji, Gaku, Kido-Nakahara, Makiko, Oda, Yoshinao, Nakahara, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918519/ https://www.ncbi.nlm.nih.gov/pubmed/36765036 http://dx.doi.org/10.1038/s41420-023-01358-5 |
Ejemplares similares
-
Nectin cell adhesion molecule 4 regulates angiogenesis through Src signaling and serves as a novel therapeutic target in angiosarcoma
por: Tanaka, Yuka, et al.
Publicado: (2022) -
Nail Apparatus Melanoma: Current Management and Future Perspectives
por: Ito, Takamichi, et al.
Publicado: (2023) -
Intra- and Inter-Tumor BRAF Heterogeneity in Acral Melanoma: An Immunohistochemical Analysis
por: Ito, Takamichi, et al.
Publicado: (2019) -
Trop2 Expression in Extramammary Paget’s Disease and Normal Skin
por: Ito, Takamichi, et al.
Publicado: (2021) -
Novel Therapeutic Targets for the Treatment of Atopic Dermatitis
por: Tsuji, Gaku, et al.
Publicado: (2023)